HR 3523
116th Congress
House
Health
Asia
Australia
Canada
Civil actions and liability
Europe
France
Germany
Health care costs and insurance
Health care coverage and access
Inflation and prices
Italy
Japan
Medicaid
Medical research
Medicare
Military medicine
Netherlands
North America
Oceania
End Price Gouging for Medications Act
Everywhere this bill has been
6 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 16, 2019
Referred to the Subcommittee on Health.
Jul 15, 2019
Referred to the Subcommittee for Indigenous Peoples of the United States.
Jun 27, 2019
Referred to the Subcommittee on Health.
Jun 27, 2019
Referred to the Subcommittee on Military Personnel.
Jun 26, 2019
Introduced in House
Jun 26, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Plain-English summary
End Price Gouging for Medications Act
This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
10